- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03298594
A Specific Cervicograph for Women Attempting at Vaginal Delivery After Cesarean Section
A Specific Cervicograph for Women Attempting at Vaginal Delivery After Cesarean Section: is the Management of Labor Improved?
Study Overview
Status
Intervention / Treatment
Detailed Description
Appropriate management of labor is essential to minimize the risk of uterine rupture in case of attempt at vaginal delivery after a cesarean section (VBAC). Dystocia is a known risk factor for uterine rupture during labor in women with previous cesarean section. Some studies have shown that this risk increases after 2 hours at the same cervical dilation during labor. The cervicograph is an important tool to detect dystocia during labor. There is currently no specific cervicograph for pregnant women with a history of cesarean section, and no study evaluated the cervicograph in the monitoring of labor for women with a scarred uterus.
The main objective is to evaluate a specific cervicograph (the graph describing the cervical dilation, included in the partograph) for pregnant women with an history of cesarean section, to improve the management of labor for women attempting at a vaginal delivery (VBAC). Women will be randomly assigned to a specific cervicograph (including an action line 2 hours after the alert line), or to the normal cervicograph (no lines).
The outcomes of this randomized trial are: appropriate detection and management of dystocia; uterine rupture; and success of VBAC.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women in labor, admitted for a VBAC at a gestational age of 37 weeks or more
- Single pregnancy
- Cephalic presentation
Exclusion Criteria:
- More than 1 previous cesarean section
- Multiple pregnancies
- Presentations other than cephalic
- History of low vertical uterotomy, classical or inverted T-shaped
- Past history of myomectomy
- Fetal death
- Fetal anomalies
- Placental anomalies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: specific cervicograph
Specific cervicograph, including an alert line (normal progression of cervical dilation, i.e. 1 cm per hour) and an action line 2 hours after the alert line.
This should be completed after the diagnose of active labor
|
Other Names:
|
|
No Intervention: Usual cervicograph
The usual cervicograph in our unit is not having lines
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detection of dystocia during labor in women with past history of cesarean section
Time Frame: From inclusion in the study (randomization usually from 2cm) until full cervical dilation.
|
Appropriate detection and management of dystocia by identifying women with: no progression of cervical dilation for more than 2 hours during labor; or slow progress, defined as a cervical dilation of less than 2 cm in 4 hours; and immediate decision of cesarean section, to be performed within 30 minutes.
|
From inclusion in the study (randomization usually from 2cm) until full cervical dilation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Uterine rupture during labor in women with past history of cesarean section
Time Frame: From inclusion in the study (randomization usually from 2cm) until delivery
|
Uterine rupture will be defined as a complete separation of the uterine scar that resulted in protrusion of fetal or placental parts in the peritoneal cavity
|
From inclusion in the study (randomization usually from 2cm) until delivery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of VBAC
Time Frame: at delivery
|
Percentage of vaginal delivery in women with past history of cesarean section
|
at delivery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 12-173 MATPED 12-036
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attempted Vaginal Delivery After a Cesarean Section
-
Ferring PharmaceuticalsTerminatedCesarean Section | Vaginal DeliveryBrazil
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedPregnancy | Repeat Cesarean Section | Vaginal Births After CesareanUnited States
-
HITEC-Institute of Medical SciencesCompletedVaginal Birth After Cesarean SectionPakistan
-
Centre Hospitalier Universitaire, AmiensRecruitingCesarean Section | Vaginal Delivery | Induction of LaborFrance
-
University of North Carolina, Chapel HillHealthwiseCompletedScar; Previous Cesarean Section | Decision Making, Shared | Vaginal Birth After CesareanUnited States
-
University of HelsinkiHelsinki University Central HospitalRecruitingPregnancy | Cesarean Section | Cesarean Delivery Affecting Newborn | Vaginal Delivery | Microbiota | Infant, Newborn | Delivery, Obstetric | Humans | Gut -Microbiota | Neonate | Microbiota, Cesarean Section, Probiotics, Dysbiosis | Feces | Gastrointestinal Microbiota | Microbiology | Gut DysbiosisFinland
-
Charite University, Berlin, GermanyCompletedCesarean Section Complications | Cesarean Delivery Affecting Newborn | Cesarean Delivery Affecting FetusGermany
-
Insel Gruppe AG, University Hospital BernRecruitingCesarean Section | Delivery, Obstetric | Obstetric DeliverySwitzerland
-
Mansoura UniversityRecruitingCesarean Delivery | Spinal Anesthesia for Cesarean SectionEgypt
-
Columbia UniversityNot yet recruitingDexmedetomidine | Postoperative Analgesia | Cesarean Delivery | Cesarean Delivery; Neuraxial Opioids | Clonidine | Spinal Anesthesia for Cesarean SectionUnited States
Clinical Trials on specific cervicograph
-
Shifa Tameer-e-Millat UniversityActive, not recruitingBalance | Cognitive Functioning of Healthy Individuals | Strength, Muscle | Quality of Life (QOL)Pakistan
-
Taipei Medical UniversityNational Science Council, TaiwanUnknownRadiographic Contrast Agent NephropathyTaiwan
-
Assistance Publique - Hôpitaux de ParisRecruitingModerate to Severe Traumatic Brain InjuryFrance
-
Universidade Cidade de Sao PauloCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); United States Department of Defense; National...RecruitingLung Cancer | Cancer of ThoraxUnited States
-
Hopital FochRecruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSub Acute Low Back Pain With Radiating Symptoms
-
Institut Cancerologie de l'OuestNot yet recruitingCaregiver Burden | OncologyFrance
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedT-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC (NPC)Head and Neck CancerUnited States